Cargando…
Recurrent Coronary Artery Vasospasm in a Patient with Hepatocellular Carcinoma Treated with Sorafenib: a Case Report and Literature Review
Tyrosine kinase inhibitors are widely used as targeted treatments for various malignancies. Sorafenib is an orally active tyrosine kinase inhibitor that blocks the signaling pathways of several growth factors. Its use is approved for various malignancies such as unresectable hepatocellular carcinoma...
Autores principales: | Lim, Dae Hyun, Yoon, Jai Hoon, Jun, Dae Won, Lee, Oh Young, Yoon, Byung Chul, Lee, Hang Rak, Kim, Kyung Soo, Choi, Ho Soon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Liver Cancer Association
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035694/ https://www.ncbi.nlm.nih.gov/pubmed/37383059 http://dx.doi.org/10.17998/jlc.20.1.67 |
Ejemplares similares
-
Efficacy of Sorafenib for the Treatment of Post-Transplant Hepatocellular Carcinoma Recurrence
por: Kang, Seong Hee, et al.
Publicado: (2018) -
Endoscopic Treatment of a Symptomatic Ileal Lipoma with Recurrent Ileocolic Intussusceptions by Using Cap-Assisted Colonoscopy
por: Lee, Eun Sung, et al.
Publicado: (2013) -
Diagnostic Performance of Serum Asialo α(1)-Acid Glycoprotein Levels to Predict Liver Cirrhosis
por: Lim, Dae Hyun, et al.
Publicado: (2021) -
Prevalence and clinical characteristics of antibiotics associated drug induced liver injury
por: Park, Jin Hwa, et al.
Publicado: (2021) -
Successful Sequential Therapy Involving Regorafenib after Failure of Sorafenib in a Patient with Recurrent Hepatocellular Carcinoma after Liver Transplantation
por: Lee, Soon Kyu, et al.
Publicado: (2020)